• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • MedChem Designer™
      • Pro-ficiency Performance Management
      • Panorama KOL Insights Engine
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Pro-ficiency | Adaptive Learning Insights (ALI)
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Pro-ficiency | Adaptive Learning & Insights (ALI)
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
Simulations Plus Announces Conference Call Details
View More
Simulations Plus Announces Conference Call Details
  • December 12, 2005
  • Press Release

Simulations Plus Announces Conference Call Details

Keywords: investor relations
Division: PBPK

Call To Be Held On Tuesday, December 13, at 4:30 PM EST

  • Read More
Simulations Plus Releases GastroPlus TM Version 5.0
  • December 8, 2005
  • Press Release

Simulations Plus Releases GastroPlus TM Version 5.0

Keywords: PBPK, pharmaceutical, physiologically based pharmacokinetics, simulation software
Software: GastroPlus®
Division: PBPK

Completion of Two-Year Development Program Adds Major New Functionalities

  • Read More
Simulations Plus Requests Extension for 10K-SB Filing
  • December 1, 2005
  • Press Release

Simulations Plus Requests Extension for 10K-SB Filing

Keywords: investor relations
Division: PBPK

Company Plans Conference Call Shortly After Release

  • Read More
Simulations Plus Announces Change in Investor Relations
  • November 28, 2005
  • Press Release

Simulations Plus Announces Change in Investor Relations

Keywords: investor relations
Division: PBPK

Function to be Moved In-House for Greater Operating Efficiency

  • Read More
Simulations Plus Acquires All Assets of Bioreason, Inc.
  • November 4, 2005
  • Press Release

Simulations Plus Acquires All Assets of Bioreason, Inc.

Keywords: Bioreason, pharmaceutical acquisition
Division: PBPK
  • Read More
Simulations Plus Announces Release of New Toxicity Prediction for ADMET Predictor™
  • October 28, 2005
  • Press Release

Simulations Plus Announces Release of New Toxicity Prediction for ADMET Predictor™

Keywords: cardiac toxicity, drug discovery, hERG, pharmacokinetic properties, predictive models, Toxicity
Software: ADMET Predictor®
Division: PBPK

hERG Potassium Channel Blocking Affinity Models Important Cardiac Toxicity

  • Read More
Simulations Plus Expands Field Sales Force
  • September 6, 2005
  • Press Release

Simulations Plus Expands Field Sales Force

Keywords: field representative, John DiBella, life sciences, marketing and sales
Division: PBPK

Product Manager to Become Full-time Field Representative

  • Read More
Simulations Plus Acquires Assets of Sage Informatics LLC
  • August 31, 2005
  • Press Release

Simulations Plus Acquires Assets of Sage Informatics LLC

Keywords: biotechnology, pharmaceutical, pharmaceutical acquisition, Sage Informatics
Division: PBPK

New Product Line and Key Employee Expand Software Offerings and Science Staff

  • Read More
Simulations Plus Reports Results for Third Fiscal Quarter of Fiscal Year 2005
  • July 8, 2005
  • Press Release

Simulations Plus Reports Results for Third Fiscal Quarter of Fiscal Year 2005

Keywords: financial results, investor relations, net revenues
Division: PBPK
  • Read More
Simulations Plus Subsidiary, Words+, Inc., Terminates Royalty and Support Agreement with Sam Communications, LLC
  • June 29, 2005
  • Press Release

Simulations Plus Subsidiary, Words+, Inc., Terminates Royalty and Support Agreement with Sam Communications, LLC

Keywords: royalty agreement, SAM Communications, Words+
Division: PBPK

Termination by Mutual Agreement to Result in Reduced Expenses

  • Read More
Simulations Plus Announces Release of ADMET Modeler™ 1.0 and Upgrade of ADMET Predictor™
  • June 16, 2005
  • Press Release

Simulations Plus Announces Release of ADMET Modeler™ 1.0 and Upgrade of ADMET Predictor™

Keywords: absorption distribution metabolism and excretion (ADME), drug discovery, molecular property prediction program, pKa prediction, Toxicity
Software: ADMET Predictor®
Division: PBPK

Name change, new features, compatibility with ADMET Predictor™

  • Read More
Simulations Plus Announces Release of DDDPlus™ 1.0
  • February 9, 2005
  • Press Release

Simulations Plus Announces Release of DDDPlus™ 1.0

Keywords: dissolution rate, dose disintegration and dissolution, drug dosage, in vitro, in vitro dissolution experiment simulation software
Software: DDDPlus™
Division: PBPK

New core product is first in industry

  • Read More
Simulations Plus Reports 1Q 2005 Financial Results
  • January 14, 2005
  • Press Release

Simulations Plus Reports 1Q 2005 Financial Results

Keywords: financial results, investor relations, net revenues
Division: PBPK
  • Read More
Simulations Plus Announces Release of ADMET Predictor™ 1.0
  • January 4, 2005
  • Press Release

Simulations Plus Announces Release of ADMET Predictor™ 1.0

Keywords: absorption distribution metabolism and excretion (ADME), absorption simulation, molecular property prediction program, The U.S. Food and Drug Administration, Toxicity, U.S. Environmental Protection Agency (EPA)
Software: ADMET Predictor®
Division: PBPK

Name change, new features, and new pricing expected to boost sales

  • Read More
Simulations Plus Reports Results for First Fiscal Quarter of Fiscal Year 2004
  • January 14, 2004
  • Press Release

Simulations Plus Reports Results for First Fiscal Quarter of Fiscal Year 2004

Keywords: financial results, investor relations
Division: PBPK

Record 1st Quarter Revenues and 8th Consecutive Profitable Quarter

  • Read More
Simulations Plus (“SLP”) Releases DDDPlus 4.0
  • June 21, 2001
  • Press Release

Simulations Plus (“SLP”) Releases DDDPlus 4.0

Keywords: immediate release capsule dosage form, in vitro dissolution, parameter sensitivity analysis, virtual trials
Software: DDDPlus™
Division: PBPK

One-of-a-Kind Product Gets Important New Capabilities

  • Read More
  • «
  • 1
  • 2
  • …
  • 25
  • 26
  • 27
  • 28
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • MedChem Designer™
  • QSP Software
  • Pro-ficiency Performance Management
  • Panorama KOL Insights Engine
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Pro-ficiency | Adaptive Learning & Insights (ALI)
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept